CELU celularity.com: Accounting Value per Share

Graphic logo of Celularity (CELU)

As an innovator in tissue regeneration, Celularity Inc. strives to make cancer therapy more accessible. This daily price chart from the GURU.Markets platform reflects the bvps trend, where the current figure stands at -1.22. Stability is provided by a mix of commercial sales and clinical trials, while biobanking optimization allows for a reduction in unit production costs for cellular products.

Celularity Corp (CELU): Share Book Value from 07/04/2022 to 10/27/2026

Celularity Inc - analytical breakdowns and key metrics (CELU)

- price and consensus price forecast:
Price Chart Celularity Corp|CELU - Price Target Chart
- market capitalization data:
Market Valuation Celularity Inc.|CELU - Enterprise Value
- book capitalization data:
Net Assets per Single Share Celularity|CELU - Net Asset Value|Market Capitalization to Book Value Ratio celularity.com|CELU - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Celularity Inc.|CELU - Long-Term Debt to Capital|Short-Term Debt to Equity Celularity Corp|CELU - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Celularity Inc.
Fundamental company valuation:celularity.com - CELU
Manufactured products of Celularity Corp

Celularity Inc. is advancing the commercialization of placental cell-based therapeutic solutions, making the estimated book value per share an indicator of the efficiency of intellectual asset capitalization. This metric reflects the portion of net assets attributable to a single share, allowing investors to assess the real value of the business net of liabilities and determine the degree of capital preservation during the R&D period.

Competitors of Celularity Inc. (CELU)

ARGX - Net Assets per Single Share|BioNTech Pharma (BNTX) - Net Assets per Single Share|ABVX: Accounting Value per Share|ADMA (admabiologics.com) - Book Value per Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Value per Share|Book Value per Share SEPN|Net Assets per Single Share Pieris Pharmaceuticals PVLA|Equity per Share savarapharma.com (SVRA)|RIGL: Book Value per Share|Net Asset Value per Share AnaptysBio Inc ANAB|ATXS: Book Value per Share|ENGN - Accounting Value per Share|Book Value per Share RAPT|JBIO (Aerovate Therapeutics) - Net Asset Value per Share|Net Assets per Single Share Aclaris Therapeutics, Inc.|Net Assets per Single Share Kyverna Therapeutics Inc. (KYTX)|Accounting Value per Share TLSA|Book Value per Share CABA (Cabaletta Bio Inc)|Net Assets per Single Share Ventyx Biosciences VTYX|Net Assets per Single Share theratech.com THTX|Avalo Therapeutics - Book Value per Share|ELDN: Book Value per Share|Net Assets per Single Share Agenus Inc AGEN|Climb Bio, Inc (CLYM) - Accounting Value of a Share|ZURA: Book Value per Share|Net Assets per Share atyrpharma.com (ATYR)|Accounting Value per Share Adagene|Book Price of a Share ikenaoncology.com IMA|STTK: Accounting Value per Share|EQ - Net Asset Value per Share|Accounting Value per Share Connect Pharma (CNTB)|IMUX - Accounting Value of a Share|atarabio.com - Book Value per Share|IFRX (InflaRx) - Net Assets per Share|Net Assets per Single Share X4 Pharma (XFOR)|Equity per Share Adicet|Book Value per Share INMB (INmune Bio, Inc.)|Accounting Value per Share barinthusbio.com BRNS|Accounting Value per Share KZR|Net Assets per Share SAB Biotherapeutics Inc. SABS|AKTX: Book Value per Share|ENLV - Accounting Value per Share|Book Value per Share QTTB|GOVX (geovax.com) - Net Asset Value per Share|Net Assets per Single Share Edesa Biotech|Net Assets per Single Share iBio Inc (IBIO)|Accounting Value per Share CARM|Book Value per Share XTLB (XTL Bio)|Bolt Biotherapeutics, Inc. (BOLT) - Net Assets per Single Share|Share Book Value HCW Biologics, Inc. HCWB|Book Value per Share Aptevo (APVO)|AIM - Accounting Value of a Share|ADTX: Book Value per Share|GRI (GRI Bio Corporation) - Book Value per Share|XRTX - Net Assets per Single Share|Accounting Value of a Share HIND|Net Assets per Single Share REVB (Revelation Biosciences, Inc.)|Accounting Value per Share Indaptus Therapeutics Inc (INDP)|Book Value per Share SCNI (Scinai)|CALI - Book Value per Share|Accounting Value per Share Affimed Therapeutics (AFMD)|ALLK - Accounting Value of a Share|hookipapharma.com - Book Value per Share|IGMS (IGM Biosciences) - Net Assets per Share|Net Assets per Single Share ITOS|Accounting Value per Share OCEA|Net Assets per Single Share TCBP (TC Biopharm)|Accounting Value per Share thirdharmonicbio.com THRD